Asset Details
Do you wish to reserve the book?
Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure?
Do you wish to request the book?
Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Video-assisted thoracoscopic surgery for thoracic empyema: primarily, or after fibrinolytic therapy failure?
2004
Overview
Traditional and modern treatments are proposed for thoracic empyema. The efficacy of video-assisted thocoscopic surgery (VATS) has been studied when the method is applied either as primary treatment for thoracic empyema or after the failure of fibrinolytic therapy.
Thirty-eight patients treated with VATS for thoracic empyema have been reviewed. Of those, 20 patients (group 1) with empyema thoracis were referred to VATS after failure of the fibrinolytic treatment. Another 18 patients (group 2) with primary empyema thoracis were treated thoracoscopically immediately when empyema was diagnosed. Both groups were staged 5, 6, or 7 according to Light's criteria.
The group 2 patients showed a higher empyema resolving rate (95% versus 85%), shorter hospital stay (4.5 versus 7.5 days), and significantly shorter duration of the procedure (70 ± 14 versus 62 ± 10 minutes) in comparison with the patients of group 1.
The VATS technique for thoracic empyema is a well-tolerated, minimally invasive technique, with excellent therapeutic results, mild postoperative complications, and reduced hospitalization. VATS should be considered as the treatment of choice for thoracic empyema, in the fibrinopurulent stage, as it is more effective when applied primarily than when applied after fibrinolytic therapy.
Publisher
Elsevier Inc,Elsevier,Elsevier Limited
Subject
/ Aged
/ Biological and medical sciences
/ Biopsy
/ Disease
/ Empyema, Pleural - drug therapy
/ Female
/ Humans
/ Light
/ Male
/ Ostomy
/ Success
/ Surgery
